Amsterdam institute for Immunology and Infectious Diseases
-
Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three-year follow-up data of a single-blind randomized controlled trial
van Huizen, A. M., van der Kraaij, G. E., Busard, C. I., Ouwerkerk, W., van den Reek, J. M. P. A., Menting, S. P., Prens, E., Rispens, T., de Vries, A., de Jong, E. M. G. J., Lambert, J., van Doorn, M. B. A. & Spuls, P. I., Sept 2023, In: Journal of the European Academy of Dermatology and Venereology. 37, 9, p. 1815-1824 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Effectiveness and patient satisfaction of a Dutch patient decision aid for psoriasis–a pilot study
van Huizen, A. M., Rietbergen, N. J., van der Kraaij, G. E., Ubbink, D. T. & Spuls, P. I., 2023, In: Journal of dermatological treatment. 34, 1, 2186157.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Adalimumab with Methotrexate vs. Adalimumab Monotherapy in Psoriasis: First-Year Results of a Single-Blind Randomized Controlled Trial
van der Kraaij, G., Busard, C., van den Reek, J., Menting, S., Musters, A., Hutten, B., de Rie, M., Ouwerkerk, W., van Bezooijen, S-J., Prens, E., Rispens, T., de Vries, A., de Jong, E., de Kort, W., Lambert, J., van Doorn, M. & Spuls, P., Sept 2022, In: Journal of Investigative Dermatology. 142, 9, p. 2375-2383.e6Research output: Contribution to journal › Article › Academic › peer-review
- All publications